Skip to main content
Equibles
CARL logo

CARL · Carlsmed, Inc. · Metrics

Track CARL — free

Use CARL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CARL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.53 -0.08 (-0.55%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$396.71M
Shares
27.30M
Volume · Oct 23 55.65K Avg daily vol (3M) 111.03K

CARL metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.53
Market cap
$396.71M

Price action

20 metrics
Price change (1W)
+8.4%
Price change (30D)
-3.8%
Price change (3M)
+34.5%
Price change (6M)
+42.3%
Price change (YTD)
+17.7%
Price change (1Y)
+11.7%
Trailing year
Price change (5Y)
—
52-week high
$16.99
52-week low
$8.83
Change from 52-week high
-14.5%
Change from 52-week low
+64.6%
Annualized volatility
70.8%
Annualized volatility (3M)
48.5%
Beta
1.2
RSI (14D)
51.2
Price vs SMA 50
-3.1%
Price vs SMA 200
+17.6%
Avg volume (3M)
111,030
Relative volume
0.5
Average dollar volume
$1.63M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
27.30M

Valuation

12 metrics
P / E (TTM)
132.1
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
5.4×
reciprocal yield 18.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.3×
reciprocal yield 16.0%
P / book
4.7
reciprocal yield 21.2%
FCF yield
-8.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
76.6%
Operating margin
-61.1%
Trailing 12 months
Net margin
-57.4%
Gross profit (TTM)
$48.50M
Operating profit (TTM)
−$38.66M
Net income (TTM)
−$36.34M
Trailing 12 months
Diluted EPS (TTM)
$0.11
FCF margin
-54.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.72

Growth

11 metrics
Revenue growth YoY
+56.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$63.30M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+492.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-43.1%
Return on assets
-30.7%
Debt / equity
0.2
Current ratio
8.8
EBITDA (TTM)
−$38.26M
Free cash flow (TTM)
−$34.58M
Quick ratio
8.7
Interest coverage
-29.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$54.86M
Latest balance sheet
Cash & equivalents
$46.24M
Total assets
$118.20M
Total debt
$15.38M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$34.15M
Capital expenditures (TTM)
$432,000
R&D (TTM)
$20.93M
SG&A (TTM)
—
Stock compensation (TTM)
$5.39M
R&D / revenue
33.1%
Stock compensation / revenue
8.5%

Ownership (13F)

9 metrics
13F filers
74
13F filer change QoQ
+8
Institutional ownership
20.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
7.3%
Private-fund adviser ownership
6.7%
Active holders' share change QoQ
+6.2%
Holder tenure
2.0
Price vs estimated holder cost
-14.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.1%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 14.3 days to cover
Days to cover
14.3d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$14,149
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1794546 CUSIP 14280C105 13F (30d) 11 filings 11 filers Visit website Investor relations